EcoR1 Capital, Director: Zymeworks ZYME Buy · Filed 24/12/27

Trade details

Type: Insider buy
Amount: $1,473,038.91
Shares · price: 101,659 sh · $14.49 a share
Held after: 14,822,590 sh
Stock: Zymeworks ZYME
Person: EcoR1 CapitalDirector
Trade date: 24/12/27
Filed: 24/12/27
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +0.7%

Zymeworks trades, last 26 weeks

What else happened in Zymeworks around then

Filed or reported within 30 days of the trade day · 24/11/27~25/01/26

EcoR1 Capital's recent trades

EcoR1 Capital10% Owner
BuyAtara Biotherapeutics
Buy
Atara Biotherapeutics
ATRA
$4.7M
507,407 sh
$4.7M
Filed 05/11
Traded 05/07
EcoR1 Capital10% Owner
SellFirst Tracks Biotherapeutics
Sell
First Tracks Biotherapeutics
TRAX
$65M
4,705,575 sh
$65M
Filed 04/22
Traded 04/20
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$37.4M
2,077,779 sh
$37.4M
Filed 01/12
Traded 01/12
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$2.6M
144,443 sh
$2.6M
Filed 01/12
Traded 01/12
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3.7M
33,931,740 sh
$3.7M
Filed 25/07/30
Traded 25/07/28

EcoR1 Capital, Director — bought $1.5M of Zymeworks ZYME · 101,659 sh @ $14.49 | Whalegun